Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine

ClinicalTrials.gov ID: NCT03282227

Public ClinicalTrials.gov record NCT03282227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, twelve-month safety study. There is a screening period followed by a run-in period to record migraine activity. Qualified subjects will receive study medication for up to twelve months for the treatment of multiple migraine attacks. Using the electronic diary (eDiary) to confirm they are experiencing a qualified migraine, subjects will self-administer the patches and respond to questions in the eDiary post treatment administration.

Study identification

NCT ID
NCT03282227
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Zosano Pharma Corporation
Industry
Enrollment
342 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 7, 2017 (Actual)
Primary completion
May 17, 2019 (Actual)
Completion
May 17, 2019 (Actual)
Last update posted
Aug 19, 2020

2017 – 2019

United States locations

U.S. sites
31
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Achieve Clinical Research Birmingham Alabama 35216 —
Elite Clinical Studies Phoenix Arizona 85018 —
Downtown L.A. Research Center Los Angeles California 90017 —
Stanford University Medical Center Palo Alto California 94304 —
Allergy Asthma Associates of Santa Clara Valley Research Center San Jose California 95117 —
California Medical Clinic for Headache Santa Monica California 90404 —
Empire Clinical Research Upland California 91786 —
Colorado Allergy Asthma Centers Denver Colorado 80230 —
Harmony Medical Research Institute Hialeah Florida 33016 —
Advanced Clinical Research Meridian Idaho 83642 —
DelRicht Research New Orleans Louisiana 70124 —
Boston Clinical Trials Boston Massachusetts 02131 —
MedVadis Research Corporation Watertown Massachusetts 02472 —
Michigan Headache and Neurological Institute Ann Arbor Michigan 48104 —
Clinical Research Institute Minneapolis Minnesota 55402 —
Clinical Research Institute Plymouth Minnesota 55441 —
StudyMetrix Research LLC City of Saint Peters Missouri 63303-3041 —
Clinvest Research Springfield Missouri 65810 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
Rochester Clinical Research Rochester New York 14609 —
Peters Medical Research High Point North Carolina 27262 —
North Carolina Clinical Research Raleigh North Carolina 27607 —
Raleigh Medical Group PMG Research Raleigh North Carolina 27609 —
Lillestol Research Fargo North Dakota 58103 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Primary Care Associates/Radiant Research Anderson South Carolina 29621 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
FutureSearch Trials of Neurology Austin Texas 78731 —
University of Texas Southwestern Medical Center - Neurology Clinic Dallas Texas 75390 —
Central Texas Health Research New Braunfels Texas 78130 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03282227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2020 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03282227 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →